Moderna said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults age 18 and older compared with its original vaccine, Spikevax.
Source: https://www.marketwatch.com/story/moder ... topstories
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
